Predictive Value of A miRNA Signature for Distant Metastasis in Lung Cancer.

Background and objective Lung cancer represents the main cause of cancer-related deaths worldwide, and non-small cell lung cancer (NSCLC) is the most main subtype. More than half of NSCLC patients have already developed distant metastasis (DM) at the time of diagnosis and have a poor prognosis. Ther...

Descripción completa

Detalles Bibliográficos
Publicado en:Chinese Journal of Lung Cancer Vol. 27; no. 12; pp. 919 - 931
Autores principales: Jingjing CONG, Anna WANG, Yingjia WANG, Xinge LI, Junjian PI, Kaijing LIU, Hongjie ZHANG, Xiaoyan YAN, Hongmei LI
Formato: research tables/charts Journal Article
Publicado: Chinese Journal of Lung Cancer Dec2024
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=183140521&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 183140521
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        10093419
        9014
      jtl: Chinese Journal of Lung Cancer
      issn: 10093419
      maglogo: N
    pubinfo:
      dt: Dec2024
      vid: 27
      iid: 12
      pid: 54191
      pub: Chinese Journal of Lung Cancer
    artinfo:
      ui:
        183140521
        183140521
        183140521
        10.3779/j.issn.1009-3419.2024.102.43
        183140521
      ppf: 919
      ppct: 12
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Predictive Value of A miRNA Signature for Distant Metastasis in Lung Cancer.
      aug:
        au:
          Jingjing CONG
          Anna WANG
          Yingjia WANG
          Xinge LI
          Junjian PI
          Kaijing LIU
          Hongjie ZHANG
          Xiaoyan YAN
          Hongmei LI
        affil: Department of Oncology, The Affiliated Hospital of Qingdao University, Qingdao 266000, China
      sug:
        subj:
          Adenocarcinoma of Lung Familial and Genetic
          Neoplasm Metastasis Familial and Genetic
          Lung Neoplasms Familial and Genetic
          Adenocarcinoma of Lung Diagnosis
          Neoplasm Metastasis Diagnosis
          Lung Neoplasms Diagnosis
          MicroRNA
          Tumor Markers, Biological
          Prediction Models
          Human
          Cancer Patients
          Comparative Studies
          Bioinformatics
          Kaplan-Meier Estimator
          ROC Curve
          Logistic Regression
          Descriptive Statistics
          Funding Source
          Gene Expression Profiling
          Predictive Value of Tests
          Adenocarcinoma of Lung Prognosis
          Neoplasm Metastasis Prognosis
          Lung Neoplasms Prognosis
          Adenocarcinoma of Lung Risk Factors
          Neoplasm Metastasis Risk Factors
          Lung Neoplasms Risk Factors
      ab: Background and objective Lung cancer represents the main cause of cancer-related deaths worldwide, and non-small cell lung cancer (NSCLC) is the most main subtype. More than half of NSCLC patients have already developed distant metastasis (DM) at the time of diagnosis and have a poor prognosis. Therefore, it is necessary to find new biomarkers for predicting NSCLC DM in order to guide subsequent treatment and thus improve the prognosis of NSCLC patients. Numerous studies have shown that microRNAs (miRNAs) are abnormally expressed in lung cancer tissues and play an important role in tumorigenesis and progression. The aim of this study is to identify differentially expressed miRNAs in lung adenocarcinoma tissues with DM group compared to those with non-distant metastasis (NDM) group, and to construct a miRNA signature for predicting DM of lung adenocarcinoma. Methods We first obtained miRNA and clinical data for patients with lung adenocarcinoma from The Cancer Genome Atlas (TCGA) database. Subsequently, bioinformatics analysis, which included different R packages, Kaplan-Meier analysis, receiver operating characteristic (ROC) curve, and a range of online analysis tools, was performed to analyze the data. Results A total of 12 differentially expressed miRNAs were identified between the DM and NDM groups, and 8 miRNAs (miR-377-5p, miR-381-5p, miR-490-5p, miR-519d-5p, miR-3136-5p, miR-320e, miR-2355-5p, miR-6784-5p) were screened for constructing a miRNA signature. The efficacy of this miRNA signature in predicting DM was good with an area under the curve (AUC) of 0.831. Logistic regression analysis showed that this miRNA signature was an independent risk factor for DM of lung adenocarcinoma. Next, target genes of the eight miRNAs were predicted, and enrichment analysis showed that these target genes were enriched in a variety of pathways, including pathways in cancer, herpes simplex virus I infection, PI3K-Akt pathway, MAPK pathway, Ras pathway, etc. Conclusion This miRNA signature has good efficacy in predicting DM of lung adenocarcinoma and has the potential to be a predictor of DM of lung adenocarcinoma.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: Chinese
    refInfo:
    holdings:
      @attributes:
        islocal: N